Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 7/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | AHR | P35869 | 2/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | NQO2 | P16083 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19080178 | 0.92 | GPR3 (0.34) | CYP1A2RAB9AGPR3PGR | |
| SCHEMBL20127309 | 0.89 | ABCG2 (0.38) | ABCG2PAX8NPC1TDP1AHR | |
| SCHEMBL19082012 | 0.88 | ABCG2 (0.38) | ABCG2PAX8NPC1TDP1AHR | |
| SCHEMBL19076925 | 0.88 | GPR3 (0.33) | CYP1A2RAB9AGPR3 | |
| SCHEMBL19079994 | 0.87 | ABCG2 (0.39) | ABCG2PAX8NPC1TDP1AHR | |
| SCHEMBL19076603 | 0.87 | AHR (0.34) | NPC1AHRCYP1A2RAB9AGPR3 | |
| SCHEMBL19081716 | 0.86 | ABCG2 (0.35) | ABCG2PAX8NPC1TDP1AHR | |
| SCHEMBL17943915 | 0.86 | TDP1 (0.37) | ABCG2PAX8NPC1TDP1AHR | |
| SCHEMBL24564374 | 0.86 | ABCG2 (0.37) | ABCG2PAX8NPC1TDP1AHR | |
| SCHEMBL19080179 | 0.86 | CYP1A1 (0.38) | ABCG2TDP1CYP1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10580999-B2 | Condensed cyclic compound and an organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-20170194571-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
| US-20170194571-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170194571-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNA1 | ABCG2 4758/4885PAX8 1759/4885NPC1 1162/4885 |
| US-10580999-B2 | Condensed cyclic compound and an organic light-emitting device including the same | CRY1, CRY2, CCNA1 | ABCG2 4758/4885PAX8 1759/4885NPC1 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.